Lanlan Li

机构：Chongqing University, Fudan University, Wuhan University, First People's Hospital of Chongqing · ORCID：0000-0002-7068-698X

发表论文 70 篇 · 总被引 1175 次 · h-index 16

代表论文

• USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart (2023 · Circulation · 被引 126)
• FOXO1 regulates bovine skeletal muscle cells differentiation by targeting MYH3 (2024 · International Journal of Biological Macromolecules · 被引 25)
• Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating Prdx1 and PI3K/AKT/FOXO1 signaling (2024 · Phytomedicine · 被引 21)
• Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome (2023 · Journal of Molecular and Cellular Cardiology · 被引 15)
• Raltitrexed induces apoptosis through activating ROS-mediated ER stress by impeding HSPA8 expression in prostate cancer cells (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 被引 14)
• Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice (2025 · Cardiovascular Research · 被引 12)